Mouse models for colorectal cancer

被引:83
作者
Heyer, J
Yang, K
Lipkin, M
Edelmann, W
Kucherlapati, R
机构
[1] Yeshiva Univ Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10461 USA
[2] Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA
[3] Strang Canc Prevent Ctr, New York, NY 10021 USA
关键词
gastrointestinal cancer; FAP; HNPCC; mouse;
D O I
10.1038/sj.onc.1203036
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Colorectal cancer (CRC) is one of the most common cancers in the Western world. Much has been learned about colorectal cancer from human inherited syndromes, such as familial adenomatous polyposis (FAP) and hereditary non-polyposis colorectal cancer (HNPCC), Mouse models for CRC were generated hg introducing mutations into the mouse genes, whose human counterparts were implicated in the onset and progression of CRC. Central among these are mice carrying mutations in the Adenomatous polyposis coli (Apc) gene. Although most of these Apc mutations share some common phenotypes as homozygous embryonic lethality and tumor predisposition, the severity of the tumor predisposition is variable. Mice with mutations in the mismatch repair genes, Msh2 and Mlh1, exhibit a mismatch repair defect and are predisposed to developing gastrointestinal cancer, lymphomas and tumors of other organ systems. Mice carrying a mutation in the Pms2 gene are predisposed to lymphomas and other tumors, Mice with a mutation in the Msh6 gene have a defect in base mismatch repair and show a tumor predisposition phenotype, Mice with mutations in Mlh1, Pms2 and Msh5 have defects in meiosis suggesting unique roles for these genes in gametogenesis.
引用
收藏
页码:5325 / 5333
页数:9
相关论文
共 78 条
[51]  
Reitmair AH, 1996, CANCER RES, V56, P3842
[52]   MSH2 DEFICIENT MICE ARE VIABLE AND SUSCEPTIBLE TO LYMPHOID TUMORS [J].
REITMAIR, AH ;
SCHMITS, R ;
EWEL, A ;
BAPAT, B ;
REDSTON, M ;
MITRI, A ;
WATERHOUSE, P ;
MITTRUCKER, HW ;
WAKEHAM, A ;
LIU, B ;
THOMASON, A ;
GRIESSER, H ;
GALLINGER, S ;
BALLHAUSEN, WG ;
FISHEL, R ;
MAK, TW .
NATURE GENETICS, 1995, 11 (01) :64-70
[53]  
Ricciardone MD, 1999, CANCER RES, V59, P290
[54]   Parallel human genome analysis: Microarray-based expression monitoring of 1000 genes [J].
Schena, M ;
Shalon, D ;
Heller, R ;
Chai, A ;
Brown, PO ;
Davis, RW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (20) :10614-10619
[55]  
Schmutte C, 1998, CANCER RES, V58, P4537
[56]   Rapid colorectal adenoma formation initiated by conditional targeting of the APC gene [J].
Shibata, H ;
Toyama, K ;
Shioya, H ;
Ito, M ;
Hirota, M ;
Hasegawa, S ;
Matsumoto, H ;
Takano, H ;
Akiyama, T ;
Toyoshima, K ;
Kanamaru, R ;
Kanegae, Y ;
Saito, I ;
Nakamura, Y ;
Shiba, K ;
Noda, H .
SCIENCE, 1997, 278 (5335) :120-123
[57]  
Shoemaker AR, 1997, CANCER RES, V57, P1999
[58]   The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo [J].
Sirard, C ;
de la Pompa, JL ;
Elia, A ;
Itie, A ;
Mirtsos, C ;
Cheung, A ;
Hahn, S ;
Wakeham, A ;
Schwartz, L ;
Kern, SE ;
Rossant, J ;
Mak, TW .
GENES & DEVELOPMENT, 1998, 12 (01) :107-119
[59]   Apc1638N:: A mouse model for familial adenomatous polyposis-associated desmoid tumors and cutaneous cysts [J].
Smits, R ;
Van Oordt, WVH ;
Luz, A ;
Zurcher, C ;
Jagmohan-Changur, S ;
Breukel, C ;
Khan, PM ;
Fodde, R .
GASTROENTEROLOGY, 1998, 114 (02) :275-283
[60]   Loss of Apc and the entire chromosome 18 but absence of mutations at the Ras and Tp53 genes in intestinal tumors from Apc1638N, a mouse model for Apc-driven carcinogenesis [J].
Smits, R ;
Kartheuser, A ;
JagmohanChangur, S ;
Leblanc, V ;
Breukel, C ;
deVries, A ;
vanKranen, H ;
vanKrieken, JH ;
Williamson, S ;
Edelmann, W ;
Kucherlapati, R ;
Kan, PM ;
Fodde, R .
CARCINOGENESIS, 1997, 18 (02) :321-327